Crossmark

Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment

Crossref DOI link: https://doi.org/10.1007/s00403-024-03688-5

Published Online: 2025-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Armijo-Borjon, Gwyneth https://orcid.org/0009-0005-7163-3125
Miranda-Aguirre, Alessandra Irais https://orcid.org/0000-0002-8171-6013
Garza-Silva, Arnulfo https://orcid.org/0000-0002-2200-1958
Fernández-Chau, Iván Francisco https://orcid.org/0009-0007-4423-2814
Sanz-Sánchez, Miguel Ángel

González-Cantú, Arnulfo https://orcid.org/0000-0003-0103-0079
Romero-Ibarguengoitia, Maria Elena https://orcid.org/0000-0002-2572-4043
License Information

Text and Data Mining valid from 2025-01-07

Version of Record valid from 2025-01-07
More Information

Article History

Received: 29 July 2024

Revised: 18 December 2024

Accepted: 20 December 2024

First Online: 7 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below